Cargando…

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology

Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xuejiao, Ma, Xingyu, Zeng, Siyu, Tang, Wansi, Xiao, Liucheng, Zhu, Chenggong, Yu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106879/ https://www.ncbi.nlm.nih.gov/pubmed/32256641 http://dx.doi.org/10.1155/2020/3568756

Ejemplares similares

Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
por: Chen, Yuting, et al.
Publicado: (2022)

Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke
por: Song, Ke, et al.
Publicado: (2022)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Berberine and Berberine-Containing Plants in Pharmacology and Therapeutics
por: Chopra, R. N., et al.
Publicado: (1932)

Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking
por: Cao, Junfeng, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
por: Han, Yunfeng, et al.
Publicado: (2021)

Pharmacological effects of berberine on mood disorders
por: Fan, Jie, et al.
Publicado: (2018)

Network pharmacology and molecular docking-based study on exploring the potential mechanism of Lycium barbarum L: In the treatment of atherosclerosis
por: Qin, Xinchen, et al.
Publicado: (2023)

Understanding the molecular mechanism of Ginkgo Folium-Forsythiae Fructus for cerebral atherosclerosis treatment using network pharmacology and molecular docking
por: Zhang, Jinfei, et al.
Publicado: (2023)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency
por: Yan, Meng, et al.
Publicado: (2015)

Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology
por: Xue, Wu, et al.
Publicado: (2022)

The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology
por: Yao, Jiuxiu, et al.
Publicado: (2023)

Integrated network pharmacology, bioinformatics, and molecular docking to explore the mechanisms of berberine regulating autophagy in breast cancer
por: Huang, Bowan, et al.
Publicado: (2023)

Potential Mechanisms of Biejiajian Pill in the Treatment of Diabetic Atherosclerosis Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
por: Zhu, Rong, et al.
Publicado: (2022)

Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model
por: Li, Qiaoping, et al.
Publicado: (2021)

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
por: Li, SiJin, et al.
Publicado: (2023)

Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular docking
por: Li, Qian, et al.
Publicado: (2023)

Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking
por: Li, Wenwen, et al.
Publicado: (2023)

The mitohormetic response as part of the cytoprotection mechanism of berberine: Berberine induces mitohormesis and mechanisms
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency [Corrigendum]
Publicado: (2016)

Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation
por: Song, Lei, et al.
Publicado: (2019)

Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms
por: Shou, Jia-Wen, et al.
Publicado: (2022)

Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis
por: Niu, Chaofeng, et al.
Publicado: (2023)

Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
por: Yuan, Jinxia, et al.
Publicado: (2022)

Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
por: Li, Jian, et al.
Publicado: (2015)

Andrographolide in atherosclerosis: integrating network pharmacology and in vitro pharmacological evaluation
por: Shi, Shuai, et al.
Publicado: (2022)

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe((−/−)) mice
por: Ma, Xiaolei, et al.
Publicado: (2020)

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology
por: Guo, Pengfei, et al.
Publicado: (2019)

Research progress on the pharmacological effects of berberine targeting mitochondria
por: Fang, Xinyi, et al.
Publicado: (2022)

Recent studies on berberine and its biological and pharmacological activities
por: Nadalin, Priscilla, et al.
Publicado: (2023)

Exploring the protective mechanism of baicalin in treatment of atherosclerosis using endothelial cells deregulation model and network pharmacology
por: Li, Mingshuang, et al.
Publicado: (2022)

Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
por: Hu, Shuangyuan, et al.
Publicado: (2022)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis
por: Matei, Daniela, et al.
Publicado: (2022)

Atherosclerosis: from biology to pharmacological treatment
por: Riccioni, Graziano, et al.
Publicado: (2012)

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis
por: Liang, Jiahua, et al.
Publicado: (2021)

Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation
por: Wang, Zundong, et al.
Publicado: (2022)

Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking
por: Lee, A Yeong, et al.
Publicado: (2020)

Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation
por: Pan, Yingying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8qt6opifbm6vu0c2mtuthreo6v